Compass Therapeutics, Inc.: shareholders and insiders

CMPXNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$0.69

November 20, 2026Market cap $124M

What Ploutos Investor adds for Compass Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 18, 2026, from their own Form 4 filings.

3 Form 4s

Bought on the market

$102.8K

2 people

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $102.8K by 2 people·no sales

  • 2025: no buys, no sales
  • 2026: bought $102.8K by 2 people, no sales
  • Nov 17, 2026Neil LernerChief Accounting Officer
    Kind
  • Oct 1, 2026Neil LernerChief Accounting Officer
    Kind
  • Sep 24, 2026Neil LernerChief Accounting Officer
    Kind
  • Apr 29, 2026Jonathan AndermanGeneral Counsel
    Kind
  • Apr 29, 2026Neil LernerChief Accounting Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Sep 25, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by CMPX's officers and directors from 2020 up to November 21, 2025, 6 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%1 On a 13DNov 10, 2026 Latest filing
  • Tang Capital Managementwith 5 more persons
    Share of class9.99%
  • Orbimed Advisorswith 1 more person
    Share of class8.90%
  • Suvretta Capital Management, LLCwith 2 more persons
    Share of class8.20%
  • BlackRock, Inc.
    Share of class5.20%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Orbimed Advisors8.9%From the filing of Aug 15, 2025

    The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the…

    From the filing of Aug 15, 2025
Fell to 5% or less (8)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • State Street4.30%Nov 10, 202613G
  • Vivo Opportunity Fund Holdings, L.P.4.00%Aug 14, 202613G/A
  • Biotechnology Value Fund L P4.30%May 15, 202613G/A
  • Blackstone Annex Master Fund L.P.3.40%Feb 13, 202613G/A
  • Commander Aggregator, LP13D4.50%Aug 18, 202513D/A
  • RTW Investments, LP0.00%Aug 14, 202513G/A
  • MPM BioImpact LLC4.10%Aug 12, 202513G/A
  • Adage Capital Management, L.P.4.36%Feb 12, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter-58%
  • Citadel Advisors (Griffin)
    In the quarter-40%
  • Millennium Mgmt (Englander)
    In the quarter-0.6%
  • D.E. Shaw
    In the quarter+754%
  • AQR Capital
    In the quarter-44%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 23.2% of its shares outstanding were held short, +3.7% since the report before.

Shares held short
41.84M
23.2%
Since the report before40.36M on Sep 30, 2026
+3.7%
5.6
7.50M
More days to cover thanof 4,578 US-listed companies with enough volume
67%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 2.85M
  • Nov 15, 2023: Shares held short 2.97M
  • Nov 30, 2023: Shares held short 2.67M
  • Dec 15, 2023: Shares held short 2.10M
  • Dec 29, 2023: Shares held short 2.27M
  • Jan 12, 2024: Shares held short 1.98M
  • Jan 31, 2024: Shares held short 2.18M
  • Feb 15, 2024: Shares held short 1.97M
  • Feb 29, 2024: Shares held short 1.84M
  • Mar 15, 2024: Shares held short 1.88M
  • Mar 28, 2024: Shares held short 1.62M
  • Apr 15, 2024: Shares held short 1.62M
  • Apr 30, 2024: Shares held short 1.64M
  • May 15, 2024: Shares held short 1.64M
  • May 31, 2024: Shares held short 1.55M
  • Jun 14, 2024: Shares held short 1.58M
  • Jun 28, 2024: Shares held short 1.82M
  • Jul 15, 2024: Shares held short 2.02M
  • Jul 31, 2024: Shares held short 1.89M
  • Aug 15, 2024: Shares held short 1.78M
  • Aug 30, 2024: Shares held short 1.86M
  • Sep 13, 2024: Shares held short 2.30M
  • Sep 30, 2024: Shares held short 2.49M
  • Oct 15, 2024: Shares held short 2.21M
  • Oct 31, 2024: Shares held short 1.79M
  • Nov 15, 2024: Shares held short 1.23M
  • Nov 29, 2024: Shares held short 1.45M
  • Dec 13, 2024: Shares held short 2.10M
  • Dec 31, 2024: Shares held short 2.21M
  • Jan 15, 2025: Shares held short 3.19M
  • Jan 31, 2025: Shares held short 2.75M
  • Feb 14, 2025: Shares held short 3.53M
  • Feb 28, 2025: Shares held short 3.70M
  • Mar 14, 2025: Shares held short 4.61M
  • Mar 31, 2025: Shares held short 6.62M
  • Apr 15, 2025: Shares held short 8.17M
  • Apr 30, 2025: Shares held short 7.63M
  • May 15, 2025: Shares held short 6.91M
  • May 30, 2025: Shares held short 7.43M
  • Jun 13, 2025: Shares held short 7.39M
  • Jun 30, 2025: Shares held short 7.39M
  • Jul 15, 2025: Shares held short 7.84M
  • Jul 31, 2025: Shares held short 8.11M
  • Aug 15, 2025: Shares held short 9.53M
  • Aug 29, 2025: Shares held short 10.25M
  • Sep 15, 2025: Shares held short 12.14M
  • Sep 30, 2025: Shares held short 14.82M
  • Oct 15, 2025: Shares held short 15.36M
  • Oct 31, 2025: Shares held short 16.70M
  • Nov 14, 2025: Shares held short 16.61M
  • Nov 28, 2025: Shares held short 17.41M
  • Dec 15, 2025: Shares held short 18.51M
  • Dec 31, 2025: Shares held short 21.59M
  • Jan 15, 2026: Shares held short 22.99M
  • Jan 30, 2026: Shares held short 21.93M
  • Feb 13, 2026: Shares held short 22.36M
  • Feb 27, 2026: Shares held short 23.01M
  • Mar 13, 2026: Shares held short 23.82M
  • Mar 31, 2026: Shares held short 26.13M
  • Apr 15, 2026: Shares held short 26.07M
  • Apr 30, 2026: Shares held short 30.42M
  • May 15, 2026: Shares held short 31.02M
  • May 29, 2026: Shares held short 33.27M
  • Jun 15, 2026: Shares held short 32.50M
  • Jun 30, 2026: Shares held short 37.14M
  • Jul 15, 2026: Shares held short 39.30M
  • Jul 31, 2026: Shares held short 39.87M
  • Aug 14, 2026: Shares held short 40.20M
  • Aug 31, 2026: Shares held short 40.79M
  • Sep 15, 2026: Shares held short 41.65M
  • Sep 30, 2026: Shares held short 40.36M
  • Oct 15, 2026: Shares held short 41.84M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading43.8% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 43.8% of the shares in the reported trades were short sales, against 41.1% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
43.8%
The 14 beforeOct 14, 2026 – Nov 2, 2026
41.1%
Change
+2.7 pts
Short sales a dayon average, of 897.2K shares
393.3K
More than atof 3,666 US-listed companies, same days
29%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 44.7%
  • Oct 15, 2026: Short sales 35.3%
  • Oct 16, 2026: Short sales 36.1%
  • Oct 19, 2026: Short sales 51.7%
  • Oct 20, 2026: Short sales 36.8%
  • Oct 21, 2026: Short sales 41.3%
  • Oct 22, 2026: Short sales 34.6%
  • Oct 23, 2026: Short sales 34.8%
  • Oct 26, 2026: Short sales 46%
  • Oct 27, 2026: Short sales 26.7%
  • Oct 28, 2026: Short sales 59.1%
  • Oct 29, 2026: Short sales 44.8%
  • Oct 30, 2026: Short sales 35.3%
  • Nov 2, 2026: Short sales 47.2%
  • Nov 3, 2026: Short sales 37.9%
  • Nov 4, 2026: Short sales 51%
  • Nov 5, 2026: Short sales 46.8%
  • Nov 6, 2026: Short sales 52.1%
  • Nov 9, 2026: Short sales 44.3%
  • Nov 10, 2026: Short sales 37.7%
  • Nov 11, 2026: Short sales 41.8%
  • Nov 12, 2026: Short sales 48.7%
  • Nov 13, 2026: Short sales 47.6%
  • Nov 16, 2026: Short sales 36.4%
  • Nov 17, 2026: Short sales 46%
  • Nov 18, 2026: Short sales 43%
  • Nov 19, 2026: Short sales 41.1%
  • Nov 20, 2026: Short sales 39.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

7.11M Insiders' shares3.95% Of the company
  • Thomas J. SchuetzCHIEF EXECUTIVE OFFICER
    Directly6.48M
  • Neil LernerChief Accounting Officer
    Directly430.0K
  • Jonathan AndermanGeneral Counsel
    Directly196.0K
  • OrbiMed Capital GP VI LLCDirector,TenPercentOwner
    Directly–
  • Carl L GordonDirector,TenPercentOwner
    Directly–

A lower bound: it counts only the 5 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

17 ETFs holding it0.14% The largest weight (XBI)
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund0.14%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.09%
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.06%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.04%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.02%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.00%
  • ONEQFidelity Nasdaq Composite Index ETF
    Weight in the fund0.00%

17 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

216 Managers, Q2 2026$363M Value of their positions
  • Q3 2025: Managers 125
  • Q4 2025: Managers 173
  • Q1 2026: Managers 202
  • Q2 2026: Managers 216

Institutional investors by quarter

The fund managers holding CMPX, quarter by quarter, from Q4 2021 to Q2 2025, 15 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 216 managers held 166M shares, worth $363M. During the quarter 65 opened a position, 51 closed one, 83 added and 43 trimmed.

The largest holders, Q2 2026

  • Tang Capital Management
    In the quarter+7.1%
  • Orbimed Advisors
    In the quarter
  • Montanova Capital
    In the quarter-1.4%
  • BlackRock
    In the quarter+19%
  • State Street
    In the quarter+49%
  • Enavate Sciences Gp
    In the quarter
  • Vivo Capital
    In the quarter-19%
  • Vanguard Capital Management
    In the quarter+1.4%
  • Palo Alto Investors
    In the quarter+285%
  • Millennium Mgmt (Englander)
    In the quarter+457%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Compass Therapeutics's filings show?

Who buys and sells is one part of Compass Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CMPX's shareholders

Didn't find what you were looking for?

Ask us
Have CMPX's insiders bought or sold?

From Sep 25, 2026 to Nov 18, 2026 Compass Therapeutics's insiders bought $27.2K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold CMPX?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $4.9M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.